Serum exosomal miR-454-3p contributes to malignant progression of lung cancer by inhibiting HHEX
Exosomal miR-454-3p enhanced the progression of NSCLC cells through HHEX. miR-454-3p may be a therapeutic target for NSCLC.
Authors
- Liuyang Yu
- Guoyong Hu
- Bolin Zhao
- Jingjing Li (ORCID: https://orcid.org/0000-0002-8875-4725)
- Guiming Chen (ORCID: https://orcid.org/0000-0002-3433-4987)
- Peng Cai (ORCID: https://orcid.org/0000-0001-9618-3427)
Institutions
- First People’s Hospital of Jingmen (CN)
Publication Details
- Journal
- Molecular and Cellular Probes
- Published
- 2025-02-16
- DOI
- https://doi.org/10.1016/j.mcp.2025.102019
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00